Aandelen in “Fabricage van farmaceutische preparaten”

Aandeel Datum Koers Evolutie
vlag Fagron 13/02 22,750 EUR
-2,99% 		-2,99%
vlag FibroGen Inc 13/02 7,500 USD
+0,27% 		+0,27%
vlag Forte Biosciences Inc 13/02 32,110 USD
+4,32% 		+4,32%
vlag Fortress Biotech Inc 13/02 11,110 USD
0,00% 		0,00%
vlag Fortress Biotech Inc 13/02 3,610 USD
+3,44% 		+3,44%

Nieuws over “Fabricage van farmaceutische preparaten”

04:19 · Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline · Persbericht

04:19 · Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline · Persbericht

04:11 · uniQure N.V. Securities Fraud Class Action Result of FDA Approval Delay and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC · Persbericht

13/02 · Nektar Therapeutics Announces Closing of $460 Million Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares · Persbericht

13/02 · Accessible Health Platforms Gain Scale Across $6T Health and Wellness Market · Persbericht

13/02 · Accessible Health Platforms Gain Scale Across $6T Health and Wellness Market · Persbericht

13/02 · Elanco Announces Updates to Board of Directors · Persbericht

13/02 · Perrigo to Release Fourth Quarter and Fiscal Year 2025 Financial Results on February 26, 2026 · Persbericht

13/02 · Insmed To Present at March 2026 Investor Conferences · Persbericht

13/02 · Immunic Announces Oversubscribed Private Placement of up to USD 400 Million to Accelerate Transformation into Commercial-Stage Company · Persbericht

12/02 · PTC Therapeutics Provides Regulatory Update on Translarna™ · Persbericht

12/02 · BioMarin Announces Closing of Private Offering of Senior Notes · Persbericht

12/02 · Karyopharm Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Company Progress · Persbericht

12/02 · Soligenix Details Recent Progress and Upcoming Milestones · Persbericht

12/02 · CEO-wissel bij Franse bigpharmaspeler Sanofi · Tijd.be (€)

De raad van bestuur van het Franse farmabedrijf Sanofi, met 1.600 werknemers in België, heeft het mandaat van Paul Hudson niet vernieuwd. Hudson, die onder druk stond om opvolgers te vinden voor Sanof...

12/02 · Apothekersbereider Fagron gaat vlot over de lat · Tijd.be (€)

Na een jaar vol overnames boekte de Belgisch-Nederlandse specialist in apothekersbereidingen Fagron een beter dan verwachte omzet- en winstgroei.

12/02 · Press Release: Belén Garijo to become Chief Executive Officer of Sanofi · Persbericht

12/02 · Fagron continues its outstanding performance in FY 2025 with 9.2% topline growth and 10.9% increase in REBITDA · Persbericht

12/02 · Fagron behoudt uitstekende prestaties in boekjaar 2025 met 9,2% omzetgroei en een stijging van de REBITDA met 10,9% · Persbericht

12/02 · Nektar Therapeutics Announces Pricing of Upsized $400 Million Public Offering · Persbericht

11/02 · Viking Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Provides Corporate Update · Persbericht

Mijn selecties